文献速递儿童内分泌与遗传代谢儿童心血管与肾脏

儿童代谢健康型与不健康型肥胖的长期心脏代谢结局

Long-Term Cardiometabolic Outcomes in Children With Metabolically Healthy and Unhealthy Obesity.
PubMed 文献 · JAMA Pediatr · 2026-01-01

结果显示,代谢健康型肥胖(MHO)儿童在成年早期2型糖尿病、高血压和血脂异常累积发病率仍显著高于普通人群,但低于代谢不健康型肥胖(MUO);BMI z评分降低至少0.25与两种肥胖类型的心血管代谢疾病风险降低均相关。

要点

  • MHO儿童至30岁时2型糖尿病、高血压和血脂异常累积发病率分别为9.1%、10.8%和5.3%,均高于普通人群。
  • MUO儿童相应累积发病率更高,分别为16.8%、18.3%和12.7%。
  • BMI z评分降低≥0.25与2型糖尿病、高血压和血脂异常风险降低相关,MHO与MUO风险降低相似。

核心结论

  • 代谢健康型肥胖儿童在成年早期仍面临显著升高的心脏代谢疾病风险,肥胖治疗应推荐给所有肥胖儿童,无论初始代谢状态。

主要发现

  • 至30岁时,2型糖尿病累积发病率在MHO为9.1%、MUO为16.8%、普通人群为0.5%。
  • 高血压累积发病率在MHO为10.8%、MUO为18.3%、普通人群为3.7%。
  • 血脂异常累积发病率在MHO为5.3%、MUO为12.7%、普通人群为0.9%。
  • BMI z评分降低至少0.25与2型糖尿病(IRR 0.22;95% CI 0.14-0.35)、高血压(IRR 0.56;95% CI 0.34-0.93)和血脂异常(IRR 0.28;95% CI 0.14-0.57)风险降低相关,MHO与MUO风险降低相似。

关键数值与推荐

  • MHO定义为无高血压、空腹血糖受损、转氨酶升高、甘油三酯升高和高密度脂蛋白胆固醇降低;否则归类为MUO。
  • BMI z评分降低至少0.25与2型糖尿病、高血压和血脂异常风险降低相关,MHO与MUO风险降低相似。

临床怎么用

  • 对所有肥胖儿童均应推荐肥胖治疗,不应仅根据初始代谢状态判断是否需要干预。
  • 以BMI z评分降低至少0.25作为治疗目标之一,可关联到心脏代谢疾病风险的降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Metabolically healthy obesity (MHO) in children has been considered a low-risk phenotype, potentially not requiring treatment. However, their long-term cardiometabolic outcomes remain unclear. OBJECTIVE: To compare the occurrence of type 2 diabetes, hypertension, dyslipidemia, and mortality up to young adulthood in children with metabolically healthy obesity (MHO), metabolically unhealthy obesity (MUO), and general population peers, and to investigate the association between obesity treatment response and disease risk. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective cohort study including children undergoing obesity treatment recorded in the Swedish Childhood Obesity Treatment Register (BORIS) between 1997 and 2020 and their general population comparators, linked with national registers. Children in the cohort with obesity were aged 7 to 17 years at obesity treatment initiation and had complete cardiometabolic data. General population comparators were matched (ratio 1:5) based on sex, birth year, and residential area. Study data were analyzed from February to March 2025. EXPOSURES: Exposures included metabolically healthy obesity (MHO), defined as the absence of high blood pressure, impaired fasting glycemia, elevated transaminases, elevated triglycerides, and low high-density lipoprotein cholesterol; otherwise, children were categorized as having metabolically unhealthy obesity (MUO). MAIN OUTCOMES AND MEASURES: Type 2 diabetes, hypertension, dyslipidemia, and mortality up to age 30 years. RESULTS: A total of 7275 children (median [first quartile {Q1}-third quartile {Q3}] age, 11.1 [9.1-13.5] years; 4004 male [55.0%]) were included, along with 35 636 general population comparators (median [Q1-Q3] age, 11.1 [9.1-13.5] years; 19 596 male [55.0%]). MHO at baseline was present in 3626 children (49.8%; median [Q1-Q3] age, 10.6 [8.8-12.8] years; 1981 male [54.6%]), and MUO was present in 3649 children (50.2%; median [Q1-Q3] age, 11.6 [9.4-14.0] years; 2023 male [55.4%]). By age 30 years, cumulative incidences were as follows: type 2 diabetes (MHO, 9.1%; MUO, 16.8%; general population, 0.5%), hypertension (MHO, 10.8%; MUO, 18.3%; general population, 3.7%), and dyslipidemia (MHO, 5.3%; MUO, 12.7%; general population, 0.9%). A reduction of at least 0.25 body mass index (BMI) z score was associated with reduced incidence rate ratio (IRR) of type 2 diabetes (IRR, 0.22; 95% CI, 0.14-0.35), hypertension (IRR, 0.56; 95% CI, 0.34-0.93), and dyslipidemia (IRR, 0.28; 95% CI, 0.14-0.57), with similar risk reduction for MHO and MUO. CONCLUSIONS AND RELEVANCE: Results of this cohort study reveal that a reduction in BMI z score of at least 0.25 was associated with similar risk reductions for both MHO and MUO. Children with MHO face a substantially increased cardiometabolic disease risk already as young adults compared with the general population. Hence, obesity treatment should be recommended for all children with obesity, regardless of initial metabolic status.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Putri RR, Danielsson P, Hagman E, et al. Long-Term Cardiometabolic Outcomes in Children With Metabolically Healthy and Unhealthy Obesity. JAMA Pediatr. 2026. PMID: 41870461. doi:10.1001/jamapediatrics.2026.0343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。